MedPath

Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.

Not Applicable
Completed
Conditions
Disbiosis
Constipation
Abdominal Pain
Diarrhea
Stress
Registration Number
NCT03234452
Lead Sponsor
Montefarmaco OTC SpA
Brief Summary

A randomized, double-blind, placebo-controlled, cross-over trial performed at one centre in Italy to explore the ability of a multistrain probiotic mixture, to modulate markers of inflammation and intestinal barrier function and gastrointestinal symptoms in healthy volunteers with self-reported anxiety.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria

Eligible subjects were healthy men and women, 20-35 years old, with a STAI scale, form Y, module 1 (state anxiety) score of ≥ 35 and ≥40, for men and women, respectively.

Exclusion Criteria

Most important exclusion criteria were history or diagnosis of GI disease, oral antibiotics within 30 days prior to the screening visit, and use of drugs, food or herbal supplements for digestive symptoms.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
NK activity45 days

Verify that Natural Killer activities concentration is significantly higher in the experimental Group compared to the placebo group

Secondary Outcome Measures
NameTimeMethod
microbiota composition investigation45 days
Gastrointestinal symptoms (abdominal pain, aerophagia, diarrhea, constipation, diarrhea/constipation alternation )45 days
IgA, IL8, TNF-Alpha, IL1045 days
Cortisol, alpha-amylase , chromogranin A45 days

Trial Locations

Locations (1)

Centro Ricerche Cliniche di Verona Srl,

🇮🇹

Verona, (Vr), Italy

Centro Ricerche Cliniche di Verona Srl,
🇮🇹Verona, (Vr), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.